Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Magnesium, zinc and aluminium complexes supported by tripodal diaminebis(aryloxido) ligands: synthesis, solid state and solution structure

Ewa Kober , Zofia Janas *, Tomasz Nerkowski and Lucjan B. Jerzykiewicz
Faculty of Chemistry, University of Wrocław, 14, F. Joliot-Curie, 50-383 Wrocław, Poland. E-mail: zofia.janas@chem.uni.wroc.pl

Received 9th April 2013 , Accepted 28th May 2013

First published on 29th May 2013


Abstract

The reactions of the diaminebis(aryloxido) ligand precursors [Me2NCH2CH2N(CH2-4-R-C6H3OH)2] [R = C(CH3)2CH2C(CH3)3, H22L11; R = CH3, H22L22] with MgnBu2, ZnEt2 and AlEt3 create complexes of general formula [M2(μ-L-κ4O,N,N,O)2] (M = Mg, 1a for L1 and 1b for L2; M = Zn, 2a for L1 and 2b for L2) and [Al2(μ-L-κ3O,N,N,O)2Et2] (3 for L1) in good yields. Compounds 1a–3 were characterized by NMR spectroscopy and ESI-MS experiments. The definitive molecular structure of 1b·CH2Cl2, 2a·H2O, 2b·CH2Cl2 and 3 was provided by a single-crystal analysis and revealed their dimeric nature with an M2O2 planar core. The L1 and L2 ligands coordinate as the dianions in a tetradentate/bridging manner in 1b, 2a, 2b and in a tridentate/bridging mode in 3. The NMR spectra showed that the solid state of these compounds is essentially retained in solution.


Introduction

Polydentate diaminebis(aryloxido) (ONNO) ligands have been used extensively in transition metal coordination chemistry for catalyst development,1,2 metalloenzyme mimicry,1,3 and cytotoxicity against particular cells1,4 as well as magnetic studies.5 The broad application range arises from the great modification possibilities either on the phenyl group or the amine one leading to the convenient variation of steric factors and donor ability of those class ligands.

A particularly convenient method for the synthesis of transition metal complexes supported by diaminebis(aryloxido) ligands is through a metathesis route that often involves main group metal derivatives e.g., Li, Na, Mg, Ca, Al as well as Zn compounds.6 Although the zinc ion has filled d-orbitals but shows many similar properties to magnesium including a similar ionic radius, complexes of these two metals are studied together. To fully exploit this method, it is necessary to identify the structure of starting materials. Up to date, only a few lithium compounds of the general formula [Li2(ONNO)] with diaminebis(aryloxido) ligands have been fully characterized.7 Also only a few alkaline earth metal complexes of the tripodal diaminebis(aryloxido) ligands have been reported. For the magnesium complex the four-coordinate, mononuclear structure is postulated based on the NMR studies while the dinuclear calcium compound with formally the hexa-coordinate environment around metal ions, both in the solid state and in solution, is well documented.8 The monomeric nature in the solid state of the zinc complexes having a four- or five-coordinate environment (depending on solvent coordination) has been established for either [Me2NCH2CH2N(CH2-2,4-tBu2-C6H2O)2]2− or [Me2NCH2CH2N(CH2-2-tBu-4-Me-C6H3O)2]2− ligands.9 However, the asymmetrical tripodal diaminebis(aryloxido) ligands, [(C5H5N)CH2CH2N{(CH2-2-tBu-4-Me-C6H2O)(CH2-C6H4O)}]2− and [(C5H5N)CH2CH2N{(CH2-2-tBu-4-OMe-C6H2O)(CH2-C6H4O)}]2−, generate dimeric zinc complexes containing a five-coordinate environment around each metal centre.5b,e In contrast, only monomeric aluminium complexes have been published which depending upon the steric properties of the phenoxy substituents and steric hindrance at the amine side-chain have different coordination geometries in the solid state either (distorted) trigonal bipyramidal or square planar.10 In addition to having various, interesting structural motifs, some of the Li, Mg, Zn and Al compounds based on the diaminebis(aryloxido) ligands have also been shown to be efficient initiators for the ring-opening polymerization (ROP) of cyclic esters such as lactide and ε-lactone.8,10,11

Following our recently reported work on the tripodal diaminebis(aryloxido) ligands shown in Fig. 1, which generate declinable lithium structures compared to their ortho and para substituted derivatives,7d we decided to examine how a lack of the substituent in the ortho-position on two phenoxo rings influences the structures of related Mg, Zn and Al complexes in the solid state and in solution.


Tetradentate diaminebis(aryloxido) ligand precursors.
Fig. 1 Tetradentate diaminebis(aryloxido) ligand precursors.

Herein, we report the synthesis and structural characterization of new Mg, Zn and Al complexes based on the ligand precursors presented in Fig. 1.

Results and discussion

We previously reported the preparation of the ligand precursors H22L11 and H22L22 (Fig. 1).7d They were synthesized in a similar way, via the straightforward, single-step Mannich condensation between N,N-dimethylethylenediamine, paraformaldehyde and 4-(1,1,3,3-tetramethylbutyl)phenol or p-cresol, respectively in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2[thin space (1/6-em)]:[thin space (1/6-em)]2 molar ratio in MeOH or EtOH.7d The ligand precursors were identified by NMR, ESI-MS and elemental analysis and the definitive molecular structure of H22L22 was provided by a single-crystal analysis. However, only qualitative information was extracted for H22L11 because of the insufficient quality of the crystal.7d Finally, recrystallization of H22L11 from the mixture of thf–MeOH (1[thin space (1/6-em)]:[thin space (1/6-em)]1) gave colourless crystals suitable for the X-ray structure determination. The crystal of H22L11 contains two independent molecules in the asymmetric unit and in Fig. 2 the molecular structure of the molecule (A) is shown. The selected parameters including hydrogen bond lengths and angles are given in the caption. The structure revealed the evidence for three intramolecular hydrogen-bond interactions between O11A–H11A⋯N12A [2.759(6) Å, 148°], O12A–H12A⋯N11A [2.720(5) Å, 146°] and O11A–H11A⋯N11A [3.114(5) Å, 120°], which may contribute to the tripodal configuration that adopts the molecule framework. The same structural feature was observed for the di-Mannich base containing ortho and para substituents on the phenolic rings.2c Furthermore, weak C–H⋯O interactions [3.384(6)–3.516(6) Å, 164–170°] stabilize the crystal packing, building a three-dimensional network.
The molecular structure of H22L11. Only one molecule (A) is shown for clarity. Hydrogen atoms except those involving in hydrogen bond-interactions are omitted. Selected parameters (bonds, Å; angles, °): N11A–C25A 1.480(7), N11A–C26A 1.460(6), N11A–C41A 1.478(6), N12A–C43A 1.467(7), N12A–C44A 1.466(7), N12A–C42A 1.469(6), C41A–C42A 1.514(7), O11A–H11A⋯N12A 2.759(6), O12A–H12A⋯N11A 2.720(5), O11A–H11A⋯N11A 3.114(5), O11A–H11A⋯N12A 148, O12A–H12A⋯N11A 146, O11A–H11A⋯N11A 120.
Fig. 2 The molecular structure of H22L11. Only one molecule (A) is shown for clarity. Hydrogen atoms except those involving in hydrogen bond-interactions are omitted. Selected parameters (bonds, Å; angles, °): N11A–C25A 1.480(7), N11A–C26A 1.460(6), N11A–C41A 1.478(6), N12A–C43A 1.467(7), N12A–C44A 1.466(7), N12A–C42A 1.469(6), C41A–C42A 1.514(7), O11A–H11A⋯N12A 2.759(6), O12A–H12A⋯N11A 2.720(5), O11A–H11A⋯N11A 3.114(5), O11A–H11A⋯N12A 148, O12A–H12A⋯N11A 146, O11A–H11A⋯N11A 120.

Key reactions to generate magnesium, zinc and aluminium series based on the L1 and L2 ligands are shown in Scheme 1 and are based on the σ-bond metathesis reaction between the ligand precursors and appropriate homoleptic metal alkyls. Complexes [M2(μ-L-κ4O,N,N,O)2] (M = Mg, 1a for L1 and 1b for L2; M = Zn, 2a for L1 and 2b for L2) and [Al2(μ-L-κ3O,N,N,O)2Et2] (3 for L1), were synthesized by the straightforward reactions of MgnBu2, ZnEt2 and AlEt3, respectively, with the ligand precursors H22L11 or H22L22 in thf or n-hexane. Unfortunately, attempts to isolate a chemically pure aluminium compound with an L2 ligand failed.


Synthetic strategy of complexes 1a–3.
Scheme 1 Synthetic strategy of complexes 1a–3.

Compounds 1a–3 were fully characterized by analytical and spectroscopic methods. The ESI-MS spectrometry was recorded as representative for characterization. The molecular ion peaks appeared at m/z: 1093.8 [1a + H]+, 701.4 [1b + H]+, 1173.7 [2a + H]+, 781.2 [2b + H]+, 1157.9 [3 + H]+. For 1b, 2a, 2b and 3, X-ray single-crystal diffraction studies were essential to unveil the nuclearity in the solid state.

As illustrated in Fig. 3–5, complexes 1b·CH2Cl2, 2a·H2O, 2b·CH2Cl2 and 3 have a dimeric character with an M2O2 planar core. The L1 and L2 ligands coordinate as the dianions (all the hydroxyl groups are deprotonated) in a tetradentate/bridging manner in 1b·CH2Cl2, 2a·H2O and 2b·CH2Cl2, specifically through two aryloxide oxygen atoms and two nitrogen atoms of the diamine group. However, in the case of 3 a tridentate/bridging mode of the L1 ligand, through two aryloxide oxygen atoms and the tripodal nitrogen atom of the diamine group, is revealed. The metal centres in each complex adopt the five-coordinate geometry with the τ values of 0.35 for Mg1 and 0.61 for Mg2 in 1b; 0.56 for Zn1 and Zn2 in 2a; 0.35 for Zn1 and 0.62 for Zn2 in 2b; 0.69 for both Al atoms in 3. On the basis of the τ values the coordination geometry around the metal centres in these compounds lies between a regular square pyramid (sqp) and a regular trigonal bipyramid (tbp).12 Nevertheless, the values of the O–M–N, O–M–O and N–M–N angles appear more appropriate for the tbp geometry and the geometry adopted by metal atoms can be accepted as a distorted trigonal bipyramid. In all structures the bridging aryloxide oxygen and the tripodal nitrogen of the L ligand coordinate in the axial positions while the remainder bound donor atoms are situated in the equatorial sites.


Molecular structures of 1b·CH2Cl2 (top) and 2b·CH2Cl2 (bottom). Hydrogen atoms and the CH2Cl2 solvent species are omitted for clarity. Selected parameters (bonds, Å; angles, °) for 1b: Mg1⋯Mg2 3.063(1), Mg1–O11 1.916(2), Mg1–O12 1.997(2), Mg1–O21 2.005(2), Mg1–N11 2.235(2), Mg1–N12 2.247(2), Mg2–O22 1.925(2), Mg2–O21 1.971(2), Mg2–O12 2.006(2), Mg2–N22 2.219(2), Mg2–N21 2.230(2), O11–Mg1–O12 112.38(7), O11–Mg1–N11 92.72(6), O21–Mg1–N11 156.32(6), N11–Mg1–N12 79.45(6), O22–Mg2–O21 118.89(6), O22–Mg2–N22 115.13(8), O21–Mg2–N21 89.94(6), O12–Mg2–N21 162.07(7), N22–Mg2–N21 80.20(6); for 2b: Zn1⋯Zn2 3.159(1), Zn1–O11 1.928(1), Zn1–O12 2.024(1), Zn1–O21 2.039(1), Zn1–N12 2.185(3), Zn1–N11 2.193(3), Zn2–O22 1.934(1), Zn2–O21 1.998(2), Zn2–O12 2.047(2), Zn2–N22 2.152(3), Zn2–N21 2.195(3), O11–Zn1–O12 110.61(5), O11–Zn1–N11 94.72(6), O21–Zn1–N11 155.73(6), N12–Zn1–N11 81.21(6), O22–Zn2–O12 104.03(5), O22–Zn2–N22 117.44(6), N22–Zn2–N21 82.11(6).
Fig. 3 Molecular structures of 1b·CH2Cl2 (top) and 2b·CH2Cl2 (bottom). Hydrogen atoms and the CH2Cl2 solvent species are omitted for clarity. Selected parameters (bonds, Å; angles, °) for 1b: Mg1⋯Mg2 3.063(1), Mg1–O11 1.916(2), Mg1–O12 1.997(2), Mg1–O21 2.005(2), Mg1–N11 2.235(2), Mg1–N12 2.247(2), Mg2–O22 1.925(2), Mg2–O21 1.971(2), Mg2–O12 2.006(2), Mg2–N22 2.219(2), Mg2–N21 2.230(2), O11–Mg1–O12 112.38(7), O11–Mg1–N11 92.72(6), O21–Mg1–N11 156.32(6), N11–Mg1–N12 79.45(6), O22–Mg2–O21 118.89(6), O22–Mg2–N22 115.13(8), O21–Mg2–N21 89.94(6), O12–Mg2–N21 162.07(7), N22–Mg2–N21 80.20(6); for 2b: Zn1⋯Zn2 3.159(1), Zn1–O11 1.928(1), Zn1–O12 2.024(1), Zn1–O21 2.039(1), Zn1–N12 2.185(3), Zn1–N11 2.193(3), Zn2–O22 1.934(1), Zn2–O21 1.998(2), Zn2–O12 2.047(2), Zn2–N22 2.152(3), Zn2–N21 2.195(3), O11–Zn1–O12 110.61(5), O11–Zn1–N11 94.72(6), O21–Zn1–N11 155.73(6), N12–Zn1–N11 81.21(6), O22–Zn2–O12 104.03(5), O22–Zn2–N22 117.44(6), N22–Zn2–N21 82.11(6).

Molecular structure of 2a·H2O. Hydrogen atoms except those involved in hydrogen bond-interactions are omitted for clarity. Selected parameters (bonds, Å; angles, °): Zn1⋯Zn2 3.160(1), Zn1–O11 1.941(2), Zn1–O12 2.001(2), Zn1–O21 2.057(2), Zn1–N11 2.201(2), Zn1–N12 2.145(2), Zn2–O12 2.065(2), Zn2–O21 1.996(2), Zn2–O22 1.947(2), Zn2–N21 2.180(2), Zn2–N22 2.143(2), O11–Zn1–O12 114.10(8), O11–Zn1–N11 93.60(8), O21–Zn1–N11 163.17(8), N11–Zn1–N12 82.58(9), O21–Zn2–O22 115.16(8), O12–Zn2–N21 161.76(8), N21–Zn2–N22 83.53(9), O1–H11⋯O11 2.960(3), O1–H12⋯O22 2.853(3), O1–H11⋯O11 162, O1–H12⋯O22 177.
Fig. 4 Molecular structure of 2a·H2O. Hydrogen atoms except those involved in hydrogen bond-interactions are omitted for clarity. Selected parameters (bonds, Å; angles, °): Zn1⋯Zn2 3.160(1), Zn1–O11 1.941(2), Zn1–O12 2.001(2), Zn1–O21 2.057(2), Zn1–N11 2.201(2), Zn1–N12 2.145(2), Zn2–O12 2.065(2), Zn2–O21 1.996(2), Zn2–O22 1.947(2), Zn2–N21 2.180(2), Zn2–N22 2.143(2), O11–Zn1–O12 114.10(8), O11–Zn1–N11 93.60(8), O21–Zn1–N11 163.17(8), N11–Zn1–N12 82.58(9), O21–Zn2–O22 115.16(8), O12–Zn2–N21 161.76(8), N21–Zn2–N22 83.53(9), O1–H11⋯O11 2.960(3), O1–H12⋯O22 2.853(3), O1–H11⋯O11 162, O1–H12⋯O22 177.

Molecular structure of 3. Hydrogen atoms are omitted for clarity. Selected parameters (bonds, Å; angles, °): Al1⋯Al2 3.008(4), Al1-O11 1.843(2), Al1–O12 1.766(2), Al1–O21 1.995(2), Al1–N11 2.118(3), Al2–O11 1.978(2), Al2–O21 1.833(2), Al2–O22 1.767(2), Al2–N21 2.131(3), O11–Al1–O12 116.01(11), O11–Al1–N11 89.34(10), O21–Al1–N11 163.82(10), O21–Al2–O2 114.68(11), O11–Al2–N21 88.83(11), O21–Al2–N21 164.02(11).
Fig. 5 Molecular structure of 3. Hydrogen atoms are omitted for clarity. Selected parameters (bonds, Å; angles, °): Al1⋯Al2 3.008(4), Al1-O11 1.843(2), Al1–O12 1.766(2), Al1–O21 1.995(2), Al1–N11 2.118(3), Al2–O11 1.978(2), Al2–O21 1.833(2), Al2–O22 1.767(2), Al2–N21 2.131(3), O11–Al1–O12 116.01(11), O11–Al1–N11 89.34(10), O21–Al1–N11 163.82(10), O21–Al2–O2 114.68(11), O11–Al2–N21 88.83(11), O21–Al2–N21 164.02(11).

The molecular structures of 1b·CH2Cl2 and 2b·CH2Cl2 with selected bond lengths and angles are shown in Fig. 3. The terminal Mg–O bond lengths of 1.916(2) and 1.925(2) Å fall in the usual range, and are as expected substantially shorter than the bridging Mg–μ-O distances of 1.995 Å (av.).13 However, while the three of the Mg–μ-O bond lengths are very similar [1.997(2), 2.005(2) and 2.006(2) Å], the fourth one (Mg2–O21) is significantly shorter by 0.03 Å. Furthermore, the values of the Mg–N distances are statistically similar (within 3σ range) although the tripodal nitrogen atom and that of the pendant arm in the L ligands differ in their electronic properties and in consequence, in the donor abilities. However, the similarity in the M–N distances in 1b·CH2Cl2 is not unusual and has been observed in the related five-coordinate zinc and cobalt complexes5a,b,e,9 as well as in the monomeric six-coordinate vanadium(V) compounds.3 The same trend in bond parameters applies to 2b·CH2Cl2 (Fig. 3), which is virtually isostructural to 1b·CH2Cl2 and a direct comparison of the M–O and M–N distances and angles is possible for the central N4M2O4 skeletons. It is worth noting that the M–O(terminal) bond lengths [Zn–O, 1.928(1) and 1.934(1) Å] are closely matched in these two molecules according to similar ionic radii of Mg2+ and Zn2+, though the Zn–N distances are significantly shorter by 0.05 Å. However the Zn–μ-O distances are notably longer by 0.03 Å than the corresponding Mg–μ-O distances in 1b·CH2Cl2, in part, it must be a reflection of the different M⋯M separation [Mg⋯Mg, 3.063(1) Å; Zn⋯Zn, 3.159(1) Å]. To our knowledge, complex 1b·CH2Cl2 is the first crystallographically characterized example of a magnesium compound bearing the diaminebis(aryloxido) ligand.

In contrast to 1b·CH2Cl2 and 2b·CH2Cl2, compound 2a crystallizes with H2O as a solvate molecule (Fig. 4). Solvating character of H2O in 2a·H2O was confirmed by successful refinements of two hydrogen bonds O1–H11⋯O11 and O1–H12⋯O22 implicated by the distances of 2.960(3) and 2.853(3) Å with the angles of 162 and 177°, respectively, that are close to linear (180°). It is clearly noticeable in the structure of 2a·H2O that the presence of the hydrogen bond interaction plays an important role in the differences between the two moieties of the dimer. In contrast to 1b·CH2Cl2 and 2b·CH2Cl2, both Zn atoms in 2a·H2O have identical τ values and in consequence the same distortion from ideal tbp geometry. The Zn–O(terminal) bond lengths of 1.941(2) and 1.947(2) Å are slightly longer than the corresponding distances in 2b·CH2Cl2 as a result of participation of O11 and O22 in the H-bonding with the H2O molecule. However, neither of these distances fall outside the range of the Zn–O distances observed in other five-coordinate aryloxide Zn(II) complexes [1.931–1.961 Å].5a,b,e,9,14 The bridge between Zn1 and Zn2 atoms formed by two oxygen atoms of the L1 ligand in 2a·H2O is asymmetric, (Zn1–O12) 2.001(2) Å and (Zn1–O21) 2.057(2) Å and the two zinc(II) centres are separated by 3.160(1) Å. Interestingly, the Zn–N(tripodal) distances of 2.201(2) and 2.180(2) Å are significantly longer than the Zn–N(dimethyl sidearm) [2.145(2) and 2.143(2) Å] but very similar to those in 2b·CH2Cl2.

It is worthwhile underlining that the diaminebis(aryloxido) ligand having tert-butyl substituents in both ortho and para positions on two phenoxo rings creates monomeric four-coordinate magnesium and zinc complexes.8 The single-crystal analysis of Zn derivatives showed to have a distorted trigonal-bipyramidal arrangement around the zinc centre formed by the donor atoms of the [Me2NCH2CH2N(CH2-2,4-tBu2-C6H2O)2]2− ligand.9 This four-coordinate Zn complex after coordination with the tetrahydrofuran molecule forms a five-coordinate trigonal-bipyramidal complex.6b However, the less bulky [(C5H5N)CH2CH2N{(CH2-2-tBu-4-R-C6H2O)(CH2-C6H4O)}]2− (R = Me, OMe) ligands containing one unsubstituted phenoxo ring and the second one with ortho and para substituent groups generate the dimeric zinc complexes in which the unsubstituted phenolate oxygen provides bridging coordination and the geometry around the two Zn ions is distorted trigonal bipyramid like in compounds 1a–2b.5e

The molecular structure of [Al2(μ-L-κ3O,N,N,O)2Et2] (3) with selected bond lengths and angles is shown in Fig. 5. The Al–O bond lengths range from 1.766(2) to 1.995(2) Å, as expected the bridging is longer than the terminal, and are similar to those found in other structures of the five-coordinate aluminium aryloxides.10,15 The Al–C distances of 1.976(3) and 1.960(3) Å are compatible with those found in the organoaluminium aryloxides.10b,15a,b,d–f,h,16 The Al–N bond lengths of 2.118(3) and 2.131(3) Å are similar to the Al–N(tripodal) distances [2.1083(13) and 2.153(2) Å] for monomeric, five-coordinate complexes [Al(L-κ4O,N,N,O)(OiPr)] [L = {Me2NCH2CH2N(CH2-2-tBu-4-OMe-C6H2O)2}2− or {Me2NCH2CH2N(CH2-2-tBu-4-Br-C6H2O)2}2−] and markedly shorter than the corresponding distances found for [Al(L-κ4O,N,N,O)X] [L = Me2NCH2CH2N(CH2-2,4-tBu2-C6H2O)2}2−; X = Me, OBn] [2.2150(16) and 2.186(4) Å].10a,b For comparison, the Al–N(tripodal) distances in the alkoxide bridged dimer [Al2(μ-L-κ4O,O,N,O)2] [L = {OCH2CH2N(CH2-2,4-Me2-C6H2O)2}3−] [2.094(1) and 2.066(1) Å] are shorter than the corresponding distances in 3.14 Particularly noteworthy in the structure of 3 is the non-coordination mode of the nitrogen sidearm. Complex 3 as a dimer is the first example among aluminium complexes bearing the diaminebis(aryloxido) ligands. In contrast to 3, the diaminebis(aryloxido) ligands having the tert-butyl substituents in both ortho and para or the tert-butyl in ortho and the methyl in para positions of the phenoxo groups with the same CH2CH2NMe2 as well as the different amine side-chains of the ligand included CH2CH2NEt2 or pyridine create solely monomeric aluminium complexes having the trigonal-bipyramidal or square-pyramidal geometry around the metal center.10

The question of whether 1b, 2a, 2b and 3 which, by X-ray crystallography, are dimeric with five-coordinate metal centres in the solid state, remain dimeric or cleave into four- (1b, 2a, 2b) or five-coordinate (in the case of 3) monomers in solution was addressed through variable-temperature (VT) 1H NMR measurements. According to the X-ray structures, the C1-symmetric 1b, 2a, 2b and 3 should have four signals for the methylene protons of the ArCH2N– units at room temperature. Thus, the NMR spin system of ArCH2N– for 1b, 2a, 2b and 3 will be AB due to their symmetry. In fact, at room temperature the proton spectra of 1b, 2a, 2b in CDCl3 and 3 in C6D5CD3 exhibit four sharp doublets for the protons of the ArCH2N– unit (δ 4.34, 4.06, 2.86, 2.65 for 1b; 4.47, 4.28, 3.03, 2.74 for 2a; 4.57, 4.42, 3.92, 3.08 for 3; 2J = 11.8–13.8 Hz). Also four multiplets for the methylene protons of the –NCH2CH2N– group (δ 3.78, 3.09, 2.92, 2.43 for 1b; 3.11, 2.89, 2.19, 2.11 for 2a) reflect the NMR spin system AA′BB′ for 1b, 2a and 2b. The same pattern of resonances appears for 1a indicating an analogous structure to 1b. However, in the case of 3, the –NCH2CH2N– group demonstrates one multiplet and one triplet in accordance with the solid state structure. Likewise, double signals for the rest of the protons of the L1 and CH3CH2 ligands are observed except the magnetically equivalent methyl protons of the sidearm NMe2 in 3 (δ 1.77 ppm, similarly as in the ligand precursor H22L11δ 1.99 ppm). Furthermore, the VT 1H NMR analysis of 1a–3 does not show any significant differences (in CDCl3 or C6D5CD3 from 233 K to 313 K), suggesting that the solid state of these compounds is essentially retained in solution within the temperature range studied.

In conclusion, a family of the diaminebis(aryloxido) magnesium, zinc and aluminium complexes 1a–3 of the tetradentate dianionic (ONNO) ligands, comprising different substituents at a position para to the phenolic oxygen atom, C(CH3)2CH2C(CH3)3 in L1 and CH3 in L2 have been prepared in good yields. Their structures have been characterized in solution by NMR spectroscopy and in the solid state by X-ray determination except for 1a allowing us to find that these substituents do not cause a remarkable change in the metal coordination geometry. The molecular structures of 1b·CH2Cl2, 2a·H2O, 2b·CH2Cl2 and 3 revealed that the lack of a substituent at the ortho position to the phenolic oxygen atom in the ligands L1 and L2 resulted in the creation of distinctly different coordination geometry around metal centres than their analogues containing both ortho and para substituents, reported in the literature. Furthermore, the NMR studies showed that the solid states of the described compounds are essentially retained in solution.

The knowledge of the structures of the diaminebis(aryloxido) magnesium and zinc complexes described here allowed us to explore the synthetic methodology for the preparation of heterometallic vanadium complexes, which are currently underway in our laboratory. Additionally, such well-defined complexes which remain in their solid state structure also in solution can be used as the potential initiators for the ROP of cyclic esters.

Experimental section

General remarks

All operations were carried out under a dry dinitrogen atmosphere, using standard Schlenk techniques. All the solvents were distilled under dinitrogen from the appropriate drying agents prior to use. Reagents were purchased from the Aldrich Chemical Co. and used without further purification unless stated otherwise. The ligand precursors H22L11 and H22L22 were prepared by a Mannich condensation following literature procedures.7d NMR spectra were performed on a Bruker ARX 500 spectrometer. The electrospray mass spectra (ESI-MS) were recorded on a Bruker MicrOTOF-Q mass spectrograph. Microanalyses were conducted on a Vario EL III CHNS Elemental Analyzer (in-house).

Synthesis of [Mg2(μ-L14O,N,N,O)2] (1a)

To an ice cold solution of H22L11 (1.20 g, 2.28 mmol) in thf (20 cm3) was added slowly MgnBu2 (2.3 cm3, 1 M in heptane, 2.28 mmol). The mixture was stirred for 10 minutes and then was allowed to reach room temperature. After stirring for 12 h at room temperature volatile materials were removed under vacuum to yield a white powder (1.1 g, 88.0%). Anal. Calcd for C68H108N4O4Mg2: C, 74.67; H, 9.96; N, 5.13. Found: C, 74.60; H, 9.92; N, 5.13. 1H NMR (500 MHz, CDCl3, 298 K): δ 7.89–6.55 (m, 12H, C6H3); 4.32 (d, 2J = 12.0 Hz, 2H, ArCH2N); 4.12 (d, 2J = 12.5 Hz, 2H, ArCH2N); 3.11 [m, 2H, NCH2CH2N(CH3)2]; 2.93 (d, 2J = 12.0 Hz, 2H, ArCH2N); 2.69 (d, 2J = 12.5 Hz, 2H, ArCH2N); 2.56, 2.01 [m, 2H NCH2CH2N(CH3)2]; 1.97, 1.94 [s, 6H, N(CH3)2]; 1.84 [m, 2H, NCH2CH2N(CH3)2]; 1.66, 1.62 [s, 4H, C(CH3)2CH2C(CH3)3]; 1.35, 1.30 [s, 12H, C(CH3)2CH2C(CH3)3]; 0.71, 0.67 [s, 18H, C(CH3)2CH2C(CH3)3]. 13C NMR (125 MHz, CDCl3, 298 K): δ 158.5, 154.6, 140.7, 138.5, 129.6, 129.0, 128.4, 128.1, 122.2, 121.0, 119.3, 116.4 (C6H3); 60.7, 59.7 (ArCH2N); 57.9, 57.6 [C(CH3)2CH2C(CH3)3]; 56.3 [NCH2CH2N(CH3)2]; 50.5 [NCH2CH2N(CH3)2]; 45.3, 44.8 [N(CH3)2]; 37.7, 38.0 [C(CH3)2CH2C(CH3)3]; 33.0, 32.6 [C(CH3)2CH2C(CH3)3]; 32.4, 32.0 [C(CH3)2CH2C(CH3)3]; 31.8, 31.5 [C(CH3)2CH2C(CH3)3]. ESI-MS: m/z: 1093.8 [1a + H]+.

Synthesis of [Mg2(μ-L24O,N,N,O)2]·CH2Cl2 (1b·CH2Cl2)

Compound 1b was prepared by an analogous procedure to that employed for 1a, but using H22L22 (0.98 g, 2.98 mmol), thf (20 cm3) and MgnBu2 (3.0 cm3, 1.0 M solution in heptane, 3.00 mmol) (0.98 g, 84.4%). The crude product was recrystallized from saturated solution in CH2Cl2 to give colourless crystals of 1b·CH2Cl2 suitable for the X-ray structure determination. Anal. Calcd for C41H54Cl2N4O4Mg2: C, 62.73; H, 6.94; Cl, 8.92; N, 7.14. Found: C, 62.66; H, 6.93; Cl, 8.90; N, 7.14. 1H NMR (500 MHz, CDCl3, 298 K): δ 7.92–6.54 (12H, C6H3); 5.30 (s, 2H, CH2Cl2); 4.34 (d, 2J = 11.9 Hz, 2H, ArCH2N); 4.06 (d, 2J = 12.5 Hz, 2H, ArCH2N); 3.78 [m, 2H, NCH2CH2N(CH3)2]; 3.09 [m, 2H, NCH2CH2N(CH3)2]; 2.92 [m, 2H, NCH2CH2N(CH3)2]; 2.86 (d, 2J = 12.0 Hz, 2H, ArCH2N); 2.65 (d, 2J = 12.5 Hz, 2H, ArCH2N); 2.43 [m, 2H, NCH2CH2N(CH3)2]; 2.20, 2.17 [s, 6H, N(CH3)2]; 2.05, 1.99 (s, 6H, ArCH3). 13C NMR (125 MHz, CDCl3, 298 K): δ 164.2, 158.6, 131.7, 131.3, 130.9, 130.5, 130.1, 128.3, 122.7, 121.6, 120.0, 117.0 (C6H3); 59.9, 59.4 (ArCH2N); 57.9 [NCH2CH2N(CH3)2]; 53.8 (CH2Cl2); 50.1 [NCH2CH2N(CH3)2]; 45.2, 45.0 [N(CH3)2]; 20.7, 20.4 (ArCH3). ESI-MS: m/z: 701.4 [1b + H]+.

Synthesis of [Zn2(μ-L14O,N,N,O)2]·H2O (2a·H2O)

Compound 2a was prepared by an analogous procedure to that employed for magnesium compounds, but using H22L11 (2.00 g, 3.90 mmol), and ZnEt2 (3.9 cm3, 1.0 M in n-hexane, 3.90 mmol), n-hexane (30 cm3). The product was precipitated as a white powder (1.90 g, 86.5%). Crystals suitable for the X-ray structure determination as 2a·H2O were obtained from CH2Cl2–CH3CN (1[thin space (1/6-em)]:[thin space (1/6-em)]1) solution upon storing in a refrigerator for a few weeks. Anal. Calcd for C68H110N4O5Zn2: C, 68.53; H, 9.31; N, 4.70. Found: C, 68.48; H, 9.29; N, 4.65. 1H NMR (500 MHz, CDCl3, 298 K): δ 8.01–6.65 (m, 12H, C6H3); 6.74 (br, s, 2H, H2O); 4.47 (d, 2J = 11.8 Hz, 2H, ArCH2N); 4.28 (d, 2J = 12.2 Hz, 2H, ArCH2N); 3.11 [m, 2H, NCH2CH2N(CH3)2]; 3.03 (d, 2J = 11.8 Hz, 2H, ArCH2N); 2.89 [m, 2H, NCH2CH2N(CH3)2]; 2.74 (d, 2J = 12.3 Hz, 2H, ArCH2N); 2.19, 2.11 [m, 2H, NCH2CH2N(CH3)2]; 1.86, 1.83 [s, 6H, N(CH3)2]; 1.67, 1.64 [s, 4H, C(CH3)2CH2C(CH3)3]; 1.35, 1.32 [s, 12H, C(CH3)2CH2C(CH3)3]; 0.71, 0.69 [s, 18H, C(CH3)2CH2C(CH3)3]. 13C NMR (125 MHz, CDCl3, 298 K): δ 156.3, 155.4, 145.6, 144.1, 128.7, 127.9, 123.4, 122.2, 120.2, 119.6, 118.2, 116.4 (C6H3); 61.7, 59.5 (ArCH2N); 58.2 [NCH2CH2N(CH3)2]; 57.5, 57.2 [C(CH3)2CH2C(CH3)3]; 49.6 [NCH2CH2N(CH3)2]; 46.5, 45.6 [N(CH3)2]; 37.9, 37.6 [C(CH3)2CH2C(CH3)3]; 32.7, 32.4 [C(CH3)2CH2C(CH3)3]; 32.4, 32.2 [C(CH3)2CH2C(CH3)3]; 32.0, 31.5 [C(CH3)2CH2C(CH3)3]. ESI-MS: m/z: 1173.7 [2a + H]+.

Synthesis of [Zn2(μ-L24O,N,N,O)2]·CH2Cl2 (2b·CH2Cl2)

The synthesis of compound 2b was carried out as described for complex 2a but using H22L22 (0.98 g, 3.0 mmol) and ZnEt2 (3 cm3 of a 1.0 M solution in n-hexane, 3.0 mmol) in thf (0.96 g, 74.4%). The crude product was recrystallized from a saturated solution in CH2Cl2 to give colourless crystals of 2b·CH2Cl2 suitable for the X-ray structure determination. Anal. Calcd for C41H54Cl2N4O4Zn2: C, 56.93; H, 6.30; Cl, 8.09; N, 6.48. Found: C, 56.87; H, 6.28; Cl, 8.07; N, 6.48. 1H NMR (500 MHz, CDCl3, 298 K): δ 8.07–6.59 (m, 12H, C6H3); 5.30 (s, 2H, CH2Cl2); 4.38 (d, 2J = 11.8 Hz, 2H, ArCH2N); 4.20 (d, 2J = 12.3 Hz, 2H, ArCH2N); 3.84 [m, 2H, NCH2CH2N(CH3)2]; 3.05 [m, 2H, NCH2CH2N(CH3)2]; 2.94 (d, 2J = 11.9 Hz, 2H, ArCH2N); 2.88 [m, 2H, NCH2CH2N(CH3)2]; 2.70 (d, 2J = 12.4 Hz, 2H, ArCH2N); 2.60 [m, 2H, NCH2CH2N(CH3)2]; 2.34, 2.31 [s, 6H, N(CH3)2]; 2.27, 1.97 (s, 6H, ArCH3). 13C NMR (125 MHz, CDCl3, 298 K): δ 165.0, 160.9, 131.6, 130.7, 125.8, 125.3, 122.9, 122.5, 121.6, 120.6, 120.1, 116.9 (C6H3); 60.5, 59.2 (ArCH2N); 57.4, 50.3 (NCH2CH2N); 45.9, 47.3 [N(CH3)2]; 20.1, 20.6 (ArCH3). ESI-MS: m/z: 781.2 [2b + H]+.

Synthesis of [Al2(μ-L13O,N,N,O)2Et2] (3)

Compound 3 was prepared by a similar procedure to that employed for 1–2, but using H22L11 (1.04 g, 1.98 mmol), n-hexane (30 cm3) and AlEt3 (2.0 cm3 of a 1.0 M solution in n-hexane, 2.00 mmol). The product was precipitated as a white powder upon cooling the reaction mixture for 24 h in a refrigerator (0.94 g, 83%). Crystals suitable for X-ray structure determination were grown from a concentrated n-hexane solution at room temperature. Anal. Calcd for C72H118N4O4Al2: C, 74.70; H, 10.27; N, 4.84. Found: C, 74.63; H, 10.25; N, 4.83. 1H NMR (500 MHz, C6D5CD3, 298 K): δ 7.11–6.47 (m, 12H, C6H3); 4.57 (d, 2J = 13.2 Hz, 2H, ArCH2N); 4.42 (d, 2J = 13.2 Hz, 2H, ArCH2N); 3.92 (d, 2J = 13.8 Hz, 2H, ArCH2N); 3.08 (d, 2J = 13.5 Hz, 2H, ArCH2N); 2.92 [br, s, 4H, NCH2CH2N(CH3)2]; 1.98 [t, 3J = 7.71 Hz, 4H, NCH2CH2N(CH3)2]; 1.77 [s, 12H, N(CH3)2]; 1.70 [br, s, 8H, C(CH3)2CH2C(CH3)3]; 1.53–1.38 (m, 6H, AlCH2CH3 overlaying with 12H, C(CH3)2CH2C(CH3)3]; 0.85, 0.77 [s, 18H, C(CH3)2CH2C(CH3)3]; 0.39, 0.15 (q, 2H, 3J = 7.31 Hz, AlCH2CH3). 13C NMR (125 MHz, C6D5CD3, 298 K): δ 159.9, 128.5, 126.2, 120.5, 116.9, 110.4 (C6H3); 56.2, 55.1 (ArCH2N); 54.6 [NCH2CH2N(CH3)2]; 52.3 [NCH2CH2N(CH3)2]; 48.6 [N(CH3)2]; 44.4, 44.1 [C(CH3)2CH2C(CH3)3]; 36.7, 36.5 [C(CH3)2CH2C(CH3)3]; 31.4, 31.3 [C(CH3)2CH2C(CH3)3]; 30.9, 30.7 [C(CH3)2CH2C(CH3)3]; 30.6, 30.5 [C(CH3)2CH2C(CH3)3]; 25.6 (AlCH2CH3); 14.3 (AlCH2CH3). ESI-MS: m/z: 1157.9 [3 + H]+.

X-Ray crystallography

Crystals of H22L11 and the title compounds (Fig. 3–5) were mounted on low-temperature diffraction loops (100 K, Oxford Cryosystem Cooler) and measured with a KUMA KM4 four-circle diffractometer equipped a CCD area detector and a graphite monochromator utilizing Cu Kα (λ = 1.5418 Å) for H22L11 and Mo Kα radiation (λ = 0.71073 Å) for 1b·CH2Cl2, 2a·H2O, 2b·CH2Cl2 and 3.17 The final cell parameters and specific data collection parameters are summarized in Table 1. The recorded data were corrected for Lorentz, polarization and absorption factors. All structures were solved by directed-methods and refined by the full-matrix least-squares program (SHELXTL).18 The carbon and oxygen bonded H-atoms were included in calculated positions but the hydrogen atoms of hydroxyl groups in 2a·H2O were located from difference Fourier map and refined without any restrains. For compound H22L11, two molecules (A and B) of H22L11 are present in the asymmetric unit. For the molecule (B), the C atoms of the methyl groups in the C(CH3)2CH2C(CH3)3 substituent are disordered and were refined at 0.5 occupancy. Also in 2a·CH2Cl2, some C atoms of the tBu moiety in the C(CH3)2CH2C(CH3)3 substituents as well as the C atoms of the –CH2CH2N(CH3)2 sidearm in 1b·CH2Cl2 and 2b·CH2Cl2 are disordered and they were refined in two positions with a 0.5 (2a·H2O) and 0.7[thin space (1/6-em)]:[thin space (1/6-em)]0.3 (1b·CH2Cl2, 2b·CH2Cl2) occupancy.
Table 1 Summary of crystal data for compounds H22L11, 1b·CH2Cl2, 2a·H2O, 2b·CH2Cl2 and 3
Compound H22L11 1b·CH2Cl2 2a·H2O 2b·CH2Cl2 3
Formula C34H56N2O2 C40H52N4O4Mg2·CH2Cl2 C68H108N4O4Zn2·H2O C40H52N4O4Zn2·CH2Cl2 C72H118Al2N4O4
Fw 524.81 786.40 1194.39 868.56 1157.66
Crystal system Orthorhombic Orthorhombic Monoclinic Orthorhombic Monoclinic
Space group Pca2(1) Pbca P21/c Pbca P21/c
a (Å) 12.115(3) 18.685(5) 14.542(3) 18.518(6) 21.042(6)
b (Å) 7.744(2) 19.275(5) 15.098(4) 19.252(6) 20.822(5)
c (Å) 69.22(2) 22.572(10) 31.839(5) 22.578(7) 16.111(4)
V3) 6494(3) 8129.3(5) 6970(3) 8049.2(4) 7057(3)
Z 8 8 4 8 4
D c (Mg m−3) 1.074 1.285 1.138 1.433 1.090
Crystal size (mm3) 0.28 × 0.18 × 0.02 0.21 × 0.19 × 0.17 0.12 × 0.13 × 0.03 0.06 × 0.03 × 0.02 0.21 × 0.13 × 0.05
μ (mm−1) 0.499 0.24 0.735 1.37 0.089
θ (°) 2.5–77 4–27.5 2.7–25.0 3–30.0 2–25.0
Reflections collected 30[thin space (1/6-em)]042 55[thin space (1/6-em)]905 77[thin space (1/6-em)]878 64[thin space (1/6-em)]294 82[thin space (1/6-em)]596
Unique reflections 10[thin space (1/6-em)]775 9240 12[thin space (1/6-em)]324 10[thin space (1/6-em)]668 12[thin space (1/6-em)]520
R (int) 0.081 0.102 0.0742 0.051 0.1640
Parameters 687 511 754 511 779
Final R1, wR2 [I > σ(I)] 0.079, 0.185 0.047, 0.083 0.037, 0.0785 0.032, 0.069 0.053, 0.102
Goodness-of-fit (S) 1.066 0.997 0.941 1.000 0.896


CCDC reference numbers: 932554 for H22L11, 874666 for 1b, 876629 for 2a, 874667 for 2b, 876628 for 3.

Acknowledgements

The authors thank the State Committee for Scientific Research (Poland) (grant No N N204 028238) and the National Scientific Center (Poland) (grant No 2012/05/N/ST5/00697) for financial support of this work. We are grateful to Prof. Tadeusz Lis for his assistance with the X-ray crystallography of compound H22L11.

References

  1. For general review of the aminebis(aryloxido) metal complexes see: O. Wichmann, R. Sillanpää and A. Lehtonen, Coord. Chem. Rev., 2012, 256, 371 CrossRef CAS.
  2. (a) F. Wolff, C. Lorber, R. Choukroun and B. Donnadieu, Inorg. Chem., 2003, 27, 7839 CrossRef; (b) F. Wolff, C. Lorber, R. Choukroun and B. Donnadieu, Eur. J. Inorg. Chem., 2004, 2861 CrossRef CAS; (c) C. Lorber, F. Wolff, R. Choukroun and L. Vendier, Eur. J. Inorg. Chem., 2005, 2850 CrossRef CAS; (d) A. Yeori, S. Groysman, I. Goldberg and M. Kol, Inorg. Chem., 2005, 44, 4466 CrossRef CAS; (e) S. Segal, I. Goldberg and M. Kol, Organometallics, 2005, 24, 200 CrossRef CAS; (f) C. L. Boyd, T. Toupance, B. R. Tyrrell, B. D. Ward, C. R. Wilson, A. R. Cowley and P. Mountford, Organometallics, 2005, 24, 309 CrossRef CAS; (g) Y. Yao, M. Ma, X. Hu, Y. Hang, Q. Shen and W.-T. Wong, Organometallics, 2005, 24, 4014 CrossRef CAS; (h) Y. Sawada, K. Matsumoto, S. Kondo, H. Watanabe, T. Ozawa, K. Suzuki, B. Saito and T. Katsuki, Angew. Chem., Int. Ed., 2006, 45, 3478 CrossRef CAS; (i) C. Lorber, Pure Appl. Chem., 2009, 81, 1205 CrossRef CAS.
  3. S. Barroso, P. Adâo, F. Madeira, M. Teresa Duarte, J. C. Pessoa and A. M. Martins, Inorg. Chem., 2010, 49, 7452 CrossRef CAS.
  4. (a) M. Shavit, D. Peri, C. M. Manna, J. S. Alexander and E. Y. Tshuva, J. Am. Chem. Soc., 2007, 129, 12098 CrossRef CAS; (b) C. M. Manna, M. Shavit and E. Y. Tshuva, J. Organomet. Chem., 2008, 693, 3947 CrossRef CAS.
  5. (a) L. Rodriguez, E. Labisbal, A. Sousa-Pedrares, J. A. García-Vázquez, J. Romero, M. L. Durán, J. A. Real and A. Sousa, Inorg. Chem., 2006, 45, 7903 CrossRef CAS; (b) A. Mukherjee, F. Lloret and R. Mukherjee, Inorg. Chem., 2008, 47, 4471 CrossRef CAS; (c) R. K. Dean, S. L. Granville, L. N. Dawe, A. Decken, K. M. Hattenhauer and C. M. Kozak, Dalton Trans., 2010, 39, 548 RSC; (d) U. K. Das, J. Bobak, C. Fowler, S. E. Hann, C. F. Petten, L. N. Dawe, A. Decken, F. M. Kerton and C. M. Kozak, Dalton Trans., 2010, 39, 5462 RSC; (e) A. Mukherjee, F. Lloret and R. Mukherjee, Eur. J. Inorg. Chem., 2010, 1032 CrossRef CAS.
  6. (a) T. J. Boyle, H. D. Pratt, L. A. M. Ottley, T. M. Alam, S. K. McIntyre, M. A. Rodrigues, J. Farrell and C. F. Campana, Inorg. Chem., 2009, 48, 9191 CrossRef CAS; (b) Q. Li, K. Nie, B. Xu, Y. Yao, Y. Hang and Q. Shen, Polyhedron, 2012, 31, 58 CrossRef CAS; (c) P. Kelly, M. R. Radlauer, A. J. Yanez, M. W. Day and T. Agapie, Dalton Trans., 2012, 41, 8086 RSC.
  7. (a) F. M. Kerton, C. M. Kozak, K. Lüttgen, C. E. Willans, R. J. Webster and A. C. Whitwood, Inorg. Chim. Acta, 2006, 259, 2819 CrossRef; (b) C.-A. Huang and C.-T. Chen, Dalton Trans., 2007, 5561 RSC; (c) W. C. Clegg, M. G. Davidson, D. V. Graham, G. Griffen, M. D. Jones, A. R. Kennedy, C. T. O'Hara, L. Russo and C. M. Thomson, Dalton Trans., 2008, 1295 RSC; (d) Z. Janas, T. Nerkowski, E. Kober, L. B. Jerzykiewicz and T. Lis, Dalton Trans., 2012, 41, 442 RSC.
  8. Y. Sarazin, R. H. Howard, D. L. Hughes, S. M. Humphrey and M. Bochman, Dalton Trans., 2006, 340 RSC.
  9. R. H. Howard, M. Bochman and J. A. Wright, Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 2006, 62, m293 Search PubMed.
  10. (a) C.-T. Chen, C.-A. Huang and B.-H. Huang, Dalton Trans., 2003, 3799 RSC; (b) L. M. Alcazar-Roman, B. J. O'Keefe, M. A. Hillmyer and W. B. Tolman, Dalton Trans., 2003, 3082 RSC; (c) K. Phomphrai, P. Chumsaeng, P. Sangtrirutnugul, P. Kongsaeree and M. Pohmakotr, Dalton Trans., 2010, 39, 1865 RSC.
  11. (a) Z. Tang and V. C. Gibson, Eur. Polym. J., 2007, 43, 150 CrossRef CAS; (b) J. Wu, T.-L. Yu, Ch.-T. Chen and Ch.-Ch. Lin, Coord. Chem. Rev., 2006, 230, 602 CrossRef.
  12. (a) A. W. Addison, T. N. Rao, J. Reedijk, J. van Rijn and G. C. Verschoor, J. Chem. Soc., Dalton Trans., 1984, 1349 RSC; (b) M.-A. Munoz-Hernandez, T. S. Keizer, P. Wei, S. Parkin and D. A. Atwood, Inorg. Chem., 2001, 40, 6782 CrossRef CAS.
  13. (a) J. Ejfler, K. Krauzy-Dziedzic, S. Szafert, L. B. Jerzykiewicz and P. Sobota, Eur. J. Inorg. Chem., 2010, 3602 CrossRef CAS; (b) R. H. Howard, C. Alonso-Moreno, L. M. Broomfield, D. L. Hughes, J. A. Wright and M. Bochmann, Dalton Trans., 2009, 8667 RSC; (c) Y. Xiao, Z. Wang and K. Ding, Macromolecules, 2006, 39, 128 CrossRef CAS; (d) L. E. Breyfogle, C. K. Williams, V. G. Young Jr., M. A. Hillmyer and W. B. Tolman, Dalton Trans., 2006, 928 RSC.
  14. S. Groysman, E. Sergeeva, I. Goldberg and M. Kol, Eur. J. Inorg. Chem., 2006, 2739 CrossRef CAS.
  15. (a) I. Taden, H.-C. Kang, W. Massa, T. S. Spaniol and J. Okuda, Eur. J. Inorg. Chem., 2000, 441 CrossRef CAS; (b) Y.-C. Liu, B.-T. Ko and C.-C. Lin, Macromolecules, 2001, 34, 6196 CrossRef CAS; (c) P. Hormnirum, E. L. Marshall, V. C. Gibson, A. J. P. White and D. J. Williams, J. Am. Chem. Soc., 2004, 126, 2688 CrossRef; (d) J. Lewiński, J. Zachara and I. Justyniak, Organometallics, 1997, 16, 4597 CrossRef; (e) J. A. Francis, S. G. Bott and A. R. Baron, J. Chem. Soc., Dalton Trans., 1998, 3305 RSC; (f) Z. Janas, L. B. Jerzykiewicz, P. Sobota and K. Szczegot, Organometallics, 2005, 24, 3987 CrossRef CAS; (g) A. L. Johnson, M. G. Davidson, Y. Pérez, M. D. Jones, N. Merle, P. R. Raithby and S. P. Richards, Dalton Trans., 2007, 5551 Search PubMed; (h) N. Tiempos-Flores, A.-J. Matta-Magaña, V. Montiel-Palma, S.-A. Costěs-Llamas and M.-A. Muñoz-Hernández, Dalton Trans., 2010, 39, 4312 RSC.
  16. C. P. Radano, G. L. Baker and M. R. Smith, J. Am. Chem. Soc., 2000, 122, 1552 CrossRef CAS.
  17. Oxford Diffraction, CrysAlis CCD and CrysAlis RED. Oxford Diffraction Poland, Wroclaw, Poland, 2009 Search PubMed.
  18. Bruker, SHELXTL. Version 6.14. Bruker AXS Inc., Madison, Wisconsin, USA, 2003 Search PubMed.

Footnote

CCDC 932554, 874666, 876629, 874667 and 876628. For crystallographic data in CIF or other electronic format see DOI: 10.1039/c3dt50938a

This journal is © The Royal Society of Chemistry 2013
Click here to see how this site uses Cookies. View our privacy policy here.